Primus Pharmaceuticals
Scottsdale, AZ
Works in Dermatology · Metabolic & endocrine · Musculoskeletal · Psychiatry
Primus Pharmaceuticals is a clinical trial sponsor based in Scottsdale, AZ. It has 3 active clinical trials with 115 planned participants, in Dermatology, Metabolic & endocrine, Musculoskeletal and Psychiatry. Since 2021 it has completed 8 trials and stopped 4 early. Its FDA record on file shows 1 inspection.
Trial track record · since 2021
FDA record
Recent FDA actions
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
3 approved drug applications with a product on the market.
Questions about Primus Pharmaceuticals
No warning letter naming Primus Pharmaceuticals is on file. FDA has published 1 inspection classification naming it.
FDA has posted 1 inspection classification naming Primus Pharmaceuticals. The latest inspection ended on 2026-07-23 and was classified VAI (voluntary action indicated). FDA posts a classification after its review, often months after the inspection ended.
Primus Pharmaceuticals is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 115 planned participants, in Dermatology, Metabolic & endocrine, Musculoskeletal, Psychiatry. Since 2021 it has completed 8 trials and stopped 4 early.
Primus Pharmaceuticals is based in Scottsdale, AZ. The address is the one on its FDA records or ClinicalTrials.gov registrations, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Primus Pharmaceuticals; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Primus Pharmaceuticals.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.